AU
CA
NZ
UK
US
IND
Kalkine has a fully transformed New Avatar.
Last update at 2026-03-10T20:00:00Z
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
Q1 Rundown: Cognex (NASDAQ:CGNX) Vs Other Specialized Technology Stocks
Thu 15 May 25, 03:34 AMMirion Technologies (MIR) is on the Move, Here's Why the Trend Could be Sustainable
Tue 13 May 25, 12:50 PMMirion Technologies First Quarter 2025 Earnings: EPS: US$0.001 (vs US$0.13 loss in 1Q 2024)
Thu 01 May 25, 11:17 AMMirion Announces First Quarter 2025 Financial Results and Updates Full Year Guidance
Tue 29 Apr 25, 08:15 PM1 Volatile Stock for Long-Term Investors and 2 to Keep Off Your Radar
Thu 24 Apr 25, 01:01 PMAll You Need to Know About Mirion Technologies (MIR) Rating Upgrade to Buy
Thu 17 Apr 25, 04:00 PM3 of Wall Street’s Favorite Stocks with Mounting Challenges
Mon 14 Apr 25, 01:04 PMA Look At The Intrinsic Value Of Mirion Technologies, Inc. (NYSE:MIR)
Wed 09 Apr 25, 11:27 AMIs Mirion Technologies, Inc. (MIR) the Best Low Cost Stock to Buy According to Billionaires?
Tue 08 Apr 25, 02:08 PMMirion to Elevate Radiopharmaceutical Production Quality with Advanced Apex-Guard Software
Tue 01 Apr 25, 08:03 PM| Breakdown | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 |
| Income before tax | -306.60000M | -164.30000M | -1.30703M | -0.00034M | -126.20000M |
| Minority interest | 11.50M | - | - | - | - |
| Net income | -324.80000M | -158.30000M | -1.04113M | -0.00034M | -122.00000M |
| Selling general administrative | 355.40M | 0.00245M | 1.37M | 0.00034M | 145.40M |
| Selling and marketing expenses | 1.70M | - | - | - | - |
| Gross profit | 317.20M | 251.80M | 0.05M | 197.00M | 188.20M |
| Reconciled depreciation | 174.50M | - | - | - | - |
| Ebit | 266.90M | -0.02300M | -1.37407M | 23.00M | 28.80M |
| Ebitda | 104.30M | 11.20M | -1.44111M | -0.00034M | - |
| Depreciation and amortization | -162.60000M | 0.04M | -0.06704M | - | - |
| Non operating income net other | - | - | - | - | - |
| Operating income | 266.90M | 11.20M | -1.37407M | -0.00034M | 16.00M |
| Other operating expenses | 181.30M | 600.40M | 1.37M | 0.00034M | - |
| Interest expense | 41.90M | 41.00M | 0.13M | 0.00000M | 0.00000M |
| Tax provision | -18.20000M | -12.40000M | -0.26590M | -5.50000M | -4.20000M |
| Interest income | 9.20M | 58.80M | 176.60M | 148.60M | 140.30M |
| Net interest income | -41.90000M | - | - | - | - |
| Extraordinary items | - | - | - | - | - |
| Non recurring | - | - | - | - | - |
| Other items | - | - | - | - | - |
| Income tax expense | 18.20M | -5.90000M | -0.26590M | -5.50000M | -4.20000M |
| Total revenue | 717.80M | 611.60M | 0.15M | 478.20M | 440.10M |
| Total operating expenses | 392.60M | 240.60M | 1.37M | 0.00034M | - |
| Cost of revenue | 400.60M | 359.80M | 0.10M | 281.20M | 251.90M |
| Total other income expense net | -573.50000M | -175.50000M | 0.07M | -0.00034M | - |
| Discontinued operations | - | - | - | - | - |
| Net income from continuing ops | -288.40000M | - | -1.04113M | -0.00034M | - |
| Net income applicable to common shares | -276.90000M | -255.80000M | -158.30000M | -119.10000M | -122.00000M |
| Preferred stock and other adjustments | - | - | - | - | - |
| Breakdown | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 |
| Total assets | 2738.70M | 3118.00M | 751.32M | 0.00500M | 0.00500M |
| Intangible assets | 650.40M | 806.90M | 326.30M | 248.30M | - |
| Earning assets | - | - | - | - | - |
| Other current assets | 33.60M | 32.20M | 0.60M | 7.60M | 4.40M |
| Total liab | 1271.50M | 1334.00M | 27.59M | 0.00064M | 0.00030M |
| Total stockholder equity | -408.50000M | 1693.20M | 723.72M | 0.00436M | 0.00470M |
| Deferred long term liab | - | - | - | - | - |
| Other current liab | 79.80M | 75.40M | 0.38M | 57.40M | 50.50M |
| Common stock | 0.02M | 750.00M | 718.73M | 0.00201M | 0.00201M |
| Capital stock | 0.00000M | 0.00000M | 718.73M | 0.00201M | 0.00201M |
| Retained earnings | -408.50000M | -131.60000M | -1.04177M | -0.00064M | -0.00030M |
| Other liab | 191.30M | 265.60M | 142.30M | 119.90M | 135.60M |
| Good will | 1418.00M | 1662.60M | 681.50M | 522.60M | - |
| Other assets | 24.80M | 24.50M | 16.70M | 8.00M | 10.40M |
| Cash | 73.50M | 84.00M | 0.38M | 0.00500M | 0.00500M |
| Cash and equivalents | 73.50M | 84.00M | 101.10M | 118.40M | - |
| Total current liabilities | 244.30M | 221.00M | 1.34M | 0.00064M | 0.00030M |
| Current deferred revenue | 83.00M | 73.00M | - | - | - |
| Net debt | 776.10M | 776.60M | -0.38325M | -0.00500M | -0.00500M |
| Short term debt | 13.80M | 13.20M | 0.81M | 0.00000M | - |
| Short long term debt | 5.30M | 3.90M | - | - | - |
| Short long term debt total | 849.60M | 860.60M | 0.81M | - | - |
| Other stockholder equity | 75.70M | 1845.50M | 6.04M | 0.00299M | 0.00299M |
| Property plant equipment | 164.90M | 169.70M | 88.80M | 75.20M | 62.90M |
| Total current assets | 480.60M | 397.20M | 0.98M | 0.00500M | 0.00500M |
| Long term investments | - | - | - | - | - |
| Net tangible assets | -670.20000M | -776.30000M | -1849.40000M | -1489.60000M | -1372.40000M |
| Short term investments | 4.30M | 4.90M | - | - | - |
| Net receivables | 221.20M | 157.40M | -0.04200M | 156.80M | 156.00M |
| Long term debt | 801.50M | 806.80M | 2056.20M | 1656.90M | - |
| Inventory | 143.30M | 123.60M | 0.01M | 90.20M | 89.30M |
| Accounts payable | 67.70M | 59.40M | 0.97M | 0.00064M | 0.00030M |
| Total permanent equity | - | - | - | - | - |
| Noncontrolling interest in consolidated entity | - | - | - | - | - |
| Temporary equity redeemable noncontrolling interests | - | - | - | - | - |
| Accumulated other comprehensive income | -75.70000M | -20.70000M | - | - | - |
| Additional paid in capital | - | - | - | - | - |
| Common stock total equity | - | - | - | - | - |
| Preferred stock total equity | - | - | - | - | - |
| Retained earnings total equity | - | - | - | - | - |
| Treasury stock | - | - | - | - | - |
| Accumulated amortization | - | - | - | - | - |
| Non currrent assets other | -116.30000M | 81.60M | 750.07M | - | - |
| Deferred long term asset charges | - | - | - | - | - |
| Non current assets total | 2233.30M | 2720.80M | 750.33M | 0.00000M | 0.00000M |
| Capital lease obligations | 42.80M | 49.90M | - | - | - |
| Long term debt total | 801.50M | 806.80M | 2056.20M | 1656.90M | - |
| Breakdown | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 |
| Investments | -39.50000M | - | - | - | - |
| Change to liabilities | 11.40M | 50.80M | 7.80M | -4.20000M | -11.10000M |
| Total cashflows from investing activities | -39.50000M | -4403.80000M | -313.30000M | -75.60000M | -25.60000M |
| Net borrowings | -6.60000M | 1610.20M | 239.00M | 120.40M | 23.60M |
| Total cash from financing activities | -7.00000M | 239.00M | 751.39M | 118.90M | 15.00M |
| Change to operating activities | 4.30M | -15.20000M | 2.30M | -6.10000M | -16.70000M |
| Net income | -276.90000M | -158.40000M | -1.04113M | -0.00034M | -122.00000M |
| Change in cash | -27.40000M | -17.60000M | 750.44M | 82.40M | 1.70M |
| Begin period cash flow | 102.40M | 120.00M | 0.00500M | 0.00500M | - |
| End period cash flow | 75.00M | 102.40M | 750.45M | 0.00500M | 0.00500M |
| Total cash from operating activities | 39.40M | 53.60M | -0.94535M | 39.50M | 14.70M |
| Issuance of capital stock | 0.00000M | - | 750.00M | 0.00000M | - |
| Depreciation | 174.50M | 83.60M | 37.30M | 68.40M | 69.50M |
| Other cashflows from investing activities | -5.30000M | -2184.30000M | -290.10000M | -55.70000M | -9.10000M |
| Dividends paid | - | - | - | - | - |
| Change to inventory | -34.80000M | 0.70M | 0.30M | 4.30M | -7.90000M |
| Change to account receivables | -19.30000M | -4.20000M | -42.50000M | 0.90M | 2.50M |
| Sale purchase of stock | 0.00000M | 900.00M | - | - | - |
| Other cashflows from financing activities | -0.40000M | 239.00M | 1.69M | -1.50000M | -8.60000M |
| Change to netincome | 176.70M | 151.20M | 122.00M | 92.70M | 96.80M |
| Capital expenditures | 34.20M | 23.20M | 6.00M | 19.90M | 16.50M |
| Change receivables | - | - | - | - | - |
| Cash flows other operating | - | - | - | - | - |
| Exchange rate changes | - | - | - | - | - |
| Cash and cash equivalents changes | - | - | - | - | - |
| Change in working capital | -54.10000M | -0.90000M | 0.10M | 0.00034M | -33.10000M |
| Stock based compensation | 31.80M | 0.90M | - | - | - |
| Other non cash items | 201.30M | 145.00M | 0.46M | - | - |
| Free cash flow | 5.20M | 30.40M | -0.94535M | 0.00000M | - |
Sector: Industrials Industry: Specialty Industrial Machinery
| Company | Change (USD) | Price (USD) | Trailing PE (x) | Forward PE (x) | Price Sales TTM (x) | Price to Book Value (x) | Enterprise Value to Revenue (x) | Enterprise Value to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| MIR Mirion Technologies Inc |
-0.06 0.28% | 21.36 | - | - | 2.81 | 1.50 | 3.70 | -115.7172 |
| SIEGY Siemens AG ADR |
3.48 2.67% | 133.93 | 17.07 | 15.75 | 1.88 | 2.76 | 2.37 | 11.38 |
| SMAWF Siemens AG Class N |
-1.68 0.62% | 268.82 | 16.98 | 15.53 | 1.83 | 2.72 | 2.35 | 11.32 |
| GE GE Aerospace |
4.59 1.43% | 326.52 | 12.87 | 26.60 | 1.61 | 4.69 | 1.61 | 8.43 |
| SBGSY Schneider Electric SA |
0.66 1.14% | 58.79 | 25.90 | 20.92 | 3.12 | 3.98 | 3.50 | 17.37 |
Mirion Technologies, Inc. provides radiation detection, measurement, analysis, and monitoring products and services in the United States, Canada, the United Kingdom, France, Germany, Finland, China, Belgium, Netherlands, Estonia, South Korea, and Japan. It operates through two segments, Medical and Industrial. The medical segment offers radiation oncology quality assurance and dosimetry solutions; patient safety solutions for diagnostic imaging and radiation therapy centers; radiation therapy quality assurance solutions for calibrating and verifying imaging and treatment accuracy; and radionuclide therapy products for nuclear medicine applications, such as shielding, product handling, medical imaging furniture, and rehabilitation products. This segment supports applications in medical diagnostics, cancer treatment, practitioner safety, and rehabilitation. The Industrial segment focuses on addressing critical radiation safety, measurement, and analysis applications; and provides personal radiation detection, identification equipment, and analysis tools. The company's products and solutions also include nuclear medicines, dosimeters, contamination and clearance monitors, reactor instrumentation and control equipment and systems, medical and industrial imaging systems and related accessories, alpha spectroscopy instruments, alpha/beta counting instruments, and gamma spectroscopy detector systems; and electrical penetration, cancer diagnostics, software, and other services. It serves hospitals, clinics and urgent care facilities, dental and veterinary offices, radiation treatment facilities, OEMs for radiation therapy, laboratories, military organizations, government agencies, industrial companies, power and utility companies, reactor design firms, and NPPs. The company was formerly known as Global Monitoring Systems, Inc. and changed its name to Mirion Technologies, Inc. in January 2006. The company was incorporated in 2005 and is headquartered in Atlanta, Georgia.
1218 Menlo Drive, Atlanta, GA, United States, 30318
| Name | Title | Year Born |
|---|---|---|
| Mr. Thomas D. Logan | Founder, CEO & Director | 1961 |
| Mr. Brian Schopfer | Chief Financial Officer | 1985 |
| Mr. Christopher Moore | Principal Accounting Officer | NA |
| Ms. Shelia Webb | Chief Technology Officer | NA |
| Ms. Emmanuelle Lee | Exec. VP, Sec. & Chief Legal Officer | NA |
| Alison Ulrich | Acting Chief HR Officer | NA |
| Mr. Loic Eloy | Pres of Industrial Group | 1977 |
| Mr. Michael Rossi | Pres of Mirion Medical | NA |
| Mr. James Cocks | Chief Product Officer | NA |
Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.
Please wait processing your request...